Matthew Canver

Investor

About

Director at Avoro Capital since 2019, evaluating mid-to-late stage biotech investments. He earned an MD/PhD from Harvard Medical School and did residency in Clinical Pathology; his PhD focused on CRISPR-based gene therapy for sickle cell disease.

Colleagues at Avoro Capital Advisors

Andy Washkowitz

Director at Avoro Capital Advisors

Behzad Aghazadeh

Managing Partner and Portfolio Manager at Avoro Capital Advisors

Billy Smith

Associate at Avoro Capital Advisors

Bryan Phillips

Deputy Chief Compliance Officer at Avoro Capital Advisors

Corie Hansen

Office Manager / Executive Assistant at Avoro Capital Advisors

David Xiang

Associate at Avoro Capital Advisors

Diane Chien

Hedge Fund Controller at Avoro Capital Advisors

Jenna Glatzer

Associate - Avoro Ventures at Avoro Capital Advisors